Stephen Grootes speaks to iDexis Managing Director Ruaan Louw, about the company’s response to SAHPRA’s instruction to recall its compounded semaglutide and tirzepatide products. iDexis disputes the regulator’s findings, insisting its compounding processes comply with legal and pharmaceutical standards, that its ingredients are sourced from internationally approved manufacturers, and that more than 214,000 patients have used its products without reported adverse events.

The Money Show is a podcast hosted by well-known journalist and radio presenter, Stephen Grootes. He explores the latest economic trends, business developments, investment opportunities, and personal finance strategies. Each episode features engaging conversations with top newsmakers, industry experts, financial advisors, entrepreneurs, and politicians, offering you thought-provoking insights to navigate the ever-changing financial landscape.  
  
Thank you for listening to a podcast from The Money Show  

 
Listen live Primedia+ weekdays from 18:00 and 20:00 (SA Time) to The Money Show with Stephen Grootes broadcast on 702 https://buff.ly/gk3y0Kj and CapeTalk https://buff.ly/NnFM3Nk 

 
For more from the show, go to https://buff.ly/7QpH0jY or find all the catch-up podcasts here https://buff.ly/PlhvUVe 

 
Subscribe to The Money Show Daily Newsletter and the Weekly Business Wrap here https://buff.ly/v5mfetc 

 
The Money Show is brought to you by Absa   
  
Follow us on social media 
  
702 on Facebook: https://www.facebook.com/TalkRadio702 
702 on TikTok: https://www.tiktok.com/@talkradio702 
702 on Instagram: https://www.instagram.com/talkradio702/ 
702 on X: https://x.com/CapeTalk 
702 on YouTube: https://www.youtube.com/@radio702 
  
CapeTalk on Facebook: https://www.facebook.com/CapeTalk 
CapeTalk on TikTok: https://www.tiktok.com/@capetalk 
CapeTalk on Instagram: https://www.instagram.com/ 
CapeTalk on X: https://x.com/Radio702 
CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567